AIDS-ONCOLOGY CLINICAL SCIENTIST DEVELOPMENT PROGRAM
AIDS-ONCOLOGY CLINICAL SCIENTIST DEVELOPMENT PROGRAM
批准号:
6376752
负责人:
ALEXANDRA M LEVINE
金额:
$24.66万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-08-11 至 2004-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Applicant's Description) As survival has increased in
patients with HIV infection, it is apparent that greater numbers of
individuals are living long enough to eventually develop malignant disease.
Further, with maturation of the AIDS epidemic, it appears that the spectrum
of HIV associated diseases has expanded, with malignant diseases becoming
more prominent as the cause of death in infected individuals. Aside from
the current AIDS-defining malignancies, including Kaposi's sarcoma,
lymphoma, and cervical cancer, additional types of cancers are now being
reported in HIV infected individuals, with significantly increased
standardized incidence ratios (SIRs) of anal cancer, Hodgkin's disease, lung
cancer, multiple myeloma and others. In terms of public health policy, it
is apparent from these data that the appropriate health care of our nation
will require specific training of oncologist in the area of HIV disease. At
the present time, there is no formalized mechanism to provide such
cross-training, nor is there a mechanism to pay for such training. The
goals of this Training Grant will be to train such individuals, who will
then be prepared to treat HIV infected patients with malignant disease; to
conduct research in this area; and, in time, to teach others these same
skills. The specific aims of the proposal are: (1) To provide
comprehensive, multidisciplinary clinical training in HIV disease to
individuals who have recently completed one or more years of formal
fellowship training in Hematology'/Oncology; (2) To provide a didactic core
curriculum, which will give a broad understanding of the advances in HIV
disease, per se, as well as the opportunistic cancers, infections, and other
illnesses which ensue; (3) To provide a didactic core curriculum, as well as
practical, day-to-day training in the area of clinical research methods, to
allow development of future clinical researchers in the area of AIDS-related
malignancy; (4) To provide didactic training in the area of basic scientific
research methods, to allow development of future clinical researchers who
will understand the principles of translational research in the area of
AIDS-malignancy; and (5) To provide close mentoring support from both
clinical and basic scientific mentors, in order to assure that the
candidates will engage in a specific translational research project related
to the field of HIV-malignancies. We will offer a two-year Fellowship
program. The first year will be spent in clinical work, with assignment of
a specific clinical mentor to each Trainee. The year will consist of
attendance at weekly general HIV/AIDS clinic; weekly AIDS/Lymphoma clinic;
weekly AIDS/KS clinic; one month on in-patient HIV/AIDS ward; three months
on inpatient AIDS malignancy ward; and attendance at didactic lectures and
symposia. The second year will emphasize training in clinical and
translational research in the area of AIDS-related malignancy, with
assignment of specific scientific mentors, and development of research
projects, as well as attendance at didactic lectures and symposia in the
area of research methods and biologic principles.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A RANDOMIZED PHASE II TRIAL OF EPOCH (AIDS)
-
批准号:7716685
-
项目类别:
-
资助金额:$3.93万
-
财政年份:2008
-
负责人:ALEXANDRA M LEVINE
-
依托单位:
A PHASE I STUDY OF VEGF- ANTISENSE OLIGONUCLEOTIDE (VEGF-AS) GIVEN AS A DAILY
-
批准号:7716712
-
项目类别:
-
资助金额:$4.45万
-
财政年份:2008
-
负责人:ALEXANDRA M LEVINE
-
依托单位:
University of Southern California
-
批准号:7130726
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2006
-
负责人:ALEXANDRA M LEVINE
-
依托单位:
A RANDOMIZED PHASE II TRIAL OF EPOCH (AIDS)
-
批准号:7603909
-
项目类别:
-
资助金额:$24.41万
-
财政年份:2006
-
负责人:ALEXANDRA M LEVINE
-
依托单位:
A PHASE I STUDY OF VEGF- ANTISENSE OLIGONUCLEOTIDE (VEGF-AS) GIVEN AS A DAILY
-
批准号:7603936
-
项目类别:
-
资助金额:$3.59万
-
财政年份:2006
-
负责人:ALEXANDRA M LEVINE
-
依托单位:
A RANDOMIZED PHASE II TRIAL OF EPOCH (AIDS)
-
批准号:7368206
-
项目类别:
-
资助金额:$111.15万
-
财政年份:2005
-
负责人:ALEXANDRA M LEVINE
-
依托单位:
A RANDOMIZED PHASE II TRIAL OF EPOCH (AIDS)
-
批准号:7200017
-
项目类别:
-
资助金额:$23.88万
-
财政年份:2004
-
负责人:ALEXANDRA M LEVINE
-
依托单位:
A RANDOMIZED PHASE II TRIAL OF EPOCH
-
批准号:7040188
-
项目类别:
-
资助金额:$2.58万
-
财政年份:2003
-
负责人:ALEXANDRA M LEVINE
-
依托单位:
AMC 005--CHOP & TRIPLE ANTIRETROVIRAL IN AIDS RELATED NON HODGKINS
-
批准号:6421159
-
项目类别:
-
资助金额:$15.58万
-
财政年份:2000
-
负责人:ALEXANDRA M LEVINE
-
依托单位:
AMC 005--CHOP & TRIPLE ANTIRETROVIRAL IN AIDS RELATED NON HODGKINS
-
批准号:6263762
-
项目类别:
-
资助金额:$3.56万
-
财政年份:1998
-
负责人:ALEXANDRA M LEVINE
-
依托单位:
AIDS-ONCOLOGY CLINICAL SCIENTIST DEVELOPMENT PROGRAM
-
批准号:6173645
-
项目类别:
-
资助金额:$33.61万
-
财政年份:1998
-
负责人:ALEXANDRA M LEVINE
-
依托单位:
AIDS-ONCOLOGY CLINICAL SCIENTIST DEVELOPMENT PROGRAM
-
批准号:2896475
-
项目类别:
-
资助金额:$33.22万
-
财政年份:1998
-
负责人:ALEXANDRA M LEVINE
-
依托单位:
AIDS-ONCOLOGY CLINICAL SCIENTIST DEVELOPMENT PROGRAM
-
批准号:2614137
-
项目类别:
-
资助金额:$18.09万
-
财政年份:1998
-
负责人:ALEXANDRA M LEVINE
-
依托单位:
COHORT STUDY
-
批准号:6241280
-
项目类别:
-
资助金额:$26.19万
-
财政年份:1997
-
负责人:ALEXANDRA M LEVINE
-
依托单位:
WOMEN'S INTERAGENCY HIV STUDY ORGANIZATION AND MANAGEMENT
-
批准号:6241281
-
项目类别:
-
资助金额:$26.19万
-
财政年份:1997
-
负责人:ALEXANDRA M LEVINE
-
依托单位:
A PHASE I STUDY OF B43 GENISTEIN IMMUNOCONJUGATE IN RECURRENT B-CELL LEUKEMIA
-
批准号:6274920
-
项目类别:
-
资助金额:$3.67万
-
财政年份:1997
-
负责人:ALEXANDRA M LEVINE
-
依托单位:
TRIAL OF SURAMIN IN PATIENTS WITH RELAPSED AIDS /NON-HODGKINS LYMPHOMA
-
批准号:6244780
-
项目类别:
-
资助金额:$3.96万
-
财政年份:1997
-
负责人:ALEXANDRA M LEVINE
-
依托单位:
TRIAL OF SURAMIN IN PATIENTS WITH RELAPSED AIDS /NON-HODGKINS LYMPHOMA
-
批准号:6274853
-
项目类别:
-
资助金额:$3.67万
-
财政年份:1997
-
负责人:ALEXANDRA M LEVINE
-
依托单位:
HEALTH CAREERS OPPORTUNITY PROGRAM
-
批准号:2651540
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1997
-
负责人:ALEXANDRA M LEVINE
-
依托单位:
AIDS-ASSOCIATED MALIGNANCIES CLINCAL TRIALS CONSORTIUM
-
批准号:2114021
-
项目类别:
-
资助金额:$20.38万
-
财政年份:1995
-
负责人:ALEXANDRA M LEVINE
-
依托单位: